Culturally-informed adaptation and psychometric properties of the Cataldo Cancer Stigma Scale in Northern Tanzania.

Tanzania cancer mental health psychometrics quality of life social support stigma

Journal

Journal of psychosocial oncology
ISSN: 1540-7586
Titre abrégé: J Psychosoc Oncol
Pays: United States
ID NLM: 8309337

Informations de publication

Date de publication:
2024
Historique:
pmc-release: 03 02 2025
pubmed: 3 8 2023
medline: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

Cancer-related stigma impacts patients' emotional health, care engagement, and cancer outcomes, but few measures of cancer stigma exist. We culturally adapted and assessed psychometric properties of the Cataldo Cancer Stigma Scale (CCSS) in Tanzania. We administered the CCSS short version (21 items), plus 12 locally-derived items, to 146 adult cancer patients. We conducted exploratory factor analysis, examined internal consistency/reliability, and assessed convergent validity with relevant measures. We identified a 17-item cancer stigma scale with strong psychometric properties and four subscales: enacted stigma, shame and blame, internalized stigma, and disclosure concerns. Stigma was rare except for disclosure concerns. Stigma was positively associated with depression and anxiety and negatively associated with social support, quality of life, and illness acceptance. The scale provides valid, culturally-informed measurement of cancer stigma in Tanzania. Future studies should assess associations with care engagement, which will inform interventions to reduce stigma and improve outcomes.

Sections du résumé

BACKGROUND UNASSIGNED
Cancer-related stigma impacts patients' emotional health, care engagement, and cancer outcomes, but few measures of cancer stigma exist. We culturally adapted and assessed psychometric properties of the Cataldo Cancer Stigma Scale (CCSS) in Tanzania.
METHODS UNASSIGNED
We administered the CCSS short version (21 items), plus 12 locally-derived items, to 146 adult cancer patients. We conducted exploratory factor analysis, examined internal consistency/reliability, and assessed convergent validity with relevant measures.
RESULTS UNASSIGNED
We identified a 17-item cancer stigma scale with strong psychometric properties and four subscales: enacted stigma, shame and blame, internalized stigma, and disclosure concerns. Stigma was rare except for disclosure concerns. Stigma was positively associated with depression and anxiety and negatively associated with social support, quality of life, and illness acceptance.
CONCLUSIONS UNASSIGNED
The scale provides valid, culturally-informed measurement of cancer stigma in Tanzania. Future studies should assess associations with care engagement, which will inform interventions to reduce stigma and improve outcomes.

Identifiants

pubmed: 37534869
doi: 10.1080/07347332.2023.2241458
pmc: PMC10837313
mid: NIHMS1922341
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

286-298

Subventions

Organisme : NIMH NIH HHS
ID : K08 MH124459
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE032216
Pays : United States
Organisme : NIDCR NIH HHS
ID : R21 DE032531
Pays : United States
Organisme : NIDCR NIH HHS
ID : K01 DE030916
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI064518
Pays : United States

Auteurs

Brandon Knettel (B)

Duke University School of Nursing, Durham, NC, USA.
Duke Global Health Institute, Duke University, Durham, NC, USA.

Linda Minja (L)

Kilimanjaro Clinical Research Institute, Moshi, Tanzania.

Elizabeth Msoka (E)

Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Kilimanjaro Christian Medical Centre Cancer Care Centre, Moshi, Tanzania.

Clotilda Tarimo (C)

Kilimanjaro Clinical Research Institute, Moshi, Tanzania.

Victor Katiti (V)

Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Kilimanjaro Christian Medical University College, Moshi, Tanzania.

Wei Pan (W)

Duke University School of Nursing, Durham, NC, USA.
Department of Population Health Sciences, Duke University, Durham, NC, USA.

Judith Mwobobia (J)

Duke Global Health Institute, Duke University, Durham, NC, USA.

Erika Juhlin (E)

Department of Head and Neck Surgery, Duke University Medical Center, Durham, NC, USA.

Elizabeth Knippler (E)

Duke University School of Nursing, Durham, NC, USA.
Duke Center for AIDS Research, Duke University, Durham, NC, USA.

Melissa Watt (M)

Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.

Gita Suneja (G)

Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA.

Stephen Kimani (S)

Department of Medicine, Division of Medical Oncology, University of Utah, Salt Lake City, UT, USA.

Dina Abouelella (D)

Department of Head and Neck Surgery, Duke University Medical Center, Durham, NC, USA.

Blandina Mmbaga (B)

Duke Global Health Institute, Duke University, Durham, NC, USA.
Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Kilimanjaro Christian Medical University College, Moshi, Tanzania.

Nosayaba Osazuwa-Peters (N)

Duke Global Health Institute, Duke University, Durham, NC, USA.
Department of Population Health Sciences, Duke University, Durham, NC, USA.
Department of Head and Neck Surgery, Duke University Medical Center, Durham, NC, USA.
Duke Cancer Institute, Durham, NC, USA.

Classifications MeSH